Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

類似資料

• Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
  著者:: Barsoumian, Hampartsoum B, 等
  出版事項: (2020)
• Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses
  著者:: Caetano, Mauricio da Silva, 等
  出版事項: (2019)
• Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
  著者:: Chen, Dawei, 等
  出版事項: (2020)
• Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
  著者:: Younes, Ahmed I., 等
  出版事項: (2020)
• Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
  著者:: Jonathan E. Schoenhals, 等
  出版事項: (2018-09-01)